EICHOR
● Completed
Study of Rebamipide Eye Drops to Treat Dry Eye
Condition: Keratoconjunctivitis Sicca · Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
About this study
The purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (dry eye).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (60)
| Harold Helms, MD | Birmingham, Alabama, United States | — |
| Michael Bernstein, MD | Birmingham, Alabama, United States | — |
| I Care! Eye Care! | Flagstaff, Arizona, United States | — |
| Harvey and Bernice Jones Eye Institute | Little Rock, Arkansas, United States | — |
| United Medical Research Institute | Inglewood, California, United States | — |
| Benchmark Research | San Francisco, California, United States | — |
| Southern California Clinical Research, Inc. | San Marino, California, United States | — |
| Colorado Eye Associates, PC | Colorado Springs, Colorado, United States | — |
| Danbury Eye Physicians and Surgeons, P.C. | Danbury, Connecticut, United States | — |
| Florida Ophthalmic Institute | Gainesville, Florida, United States | — |
| Florida Wellcare Alliance, L.C. | Inverness, Florida, United States | — |
| Shettle Eye Center | Largo, Florida, United States | — |
+ 48 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.